Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats

Hyperlipidemia is a major component of metabolic syndrome, and regarded as one of the main risk factors causing metabolic diseases. We have developed a therapeutic drug, akebia saponin D (ASD), and determined its anti-hyperlipidemia activity and the potential mechanism(s) of action by analyzing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Peipei, Yang, Xiaolin, Yang, Zhonglin, Huang, Wenzhe, Kou, Junping, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479315/
https://www.ncbi.nlm.nih.gov/pubmed/30939835
http://dx.doi.org/10.3390/molecules24071268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479315/
https://www.ncbi.nlm.nih.gov/pubmed/30939835
http://dx.doi.org/10.3390/molecules24071268

Ejemplares similares